Acadia Pharmaceuticals buy Needham & Company LLC
Start price
24.01.24
/
50%
€24.80
Target price
24.01.25
€33.86
Performance (%)
-43.21%
Price
13.06.24
€14.06
Summary
This prediction is currently active. Massive losses of -43.21% have been the result for the BUY prediction by Needham___Company_LL. This prediction currently runs until 24.01.25. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Acadia Pharmaceuticals | 0.214% | 0.214% |
iShares Core DAX® | -1.816% | -2.419% |
iShares Nasdaq 100 | 4.333% | 8.073% |
iShares Nikkei 225® | 0.657% | 1.234% |
iShares S&P 500 | 2.968% | 4.613% |
Comments by Needham___Company_LL for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $37.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Needham___Company_LL for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€15.02
09.05.24
09.05.24
€27.88
09.05.25
09.05.25
-6.39%
13.06.24
13.06.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€16.56
09.04.24
09.04.24
€29.40
09.04.25
09.04.25
-14.92%
13.06.24
13.06.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€18.20
12.03.24
12.03.24
€29.32
12.03.25
12.03.25
-22.77%
13.06.24
13.06.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.60
28.02.24
28.02.24
€33.24
28.02.25
28.02.25
-34.93%
13.06.24
13.06.24